Cargando…
Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana
OBJECTIVE: To evaluate dry eye disease and meibomian gland dysfunction among type 2 diabetes patients METHODS: A hospital-based cross-sectional study was conducted. Parameters assessed included meibum expressibility and quality, Schirmer test 1, tear breakup time (TBUT), ocular surface staining, bli...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Makerere Medical School
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382471/ https://www.ncbi.nlm.nih.gov/pubmed/36032480 http://dx.doi.org/10.4314/ahs.v22i1.36 |
_version_ | 1784769287237402624 |
---|---|
author | Abu, Emmanuel K Ofori, Amanfo O Boadi-Kusi, Samuel B Ocansey, Stephen Yankah, Richard K Kyei, Samuel Awuku, Asante Y |
author_facet | Abu, Emmanuel K Ofori, Amanfo O Boadi-Kusi, Samuel B Ocansey, Stephen Yankah, Richard K Kyei, Samuel Awuku, Asante Y |
author_sort | Abu, Emmanuel K |
collection | PubMed |
description | OBJECTIVE: To evaluate dry eye disease and meibomian gland dysfunction among type 2 diabetes patients METHODS: A hospital-based cross-sectional study was conducted. Parameters assessed included meibum expressibility and quality, Schirmer test 1, tear breakup time (TBUT), ocular surface staining, blink rates and Ocular Surface Disease Index (OSDI) scores. Dry eye was diagnosed based on a combination of subjective symptoms, tear function and ocular surface staining. RESULTS: Prevalence of DED and MGD were 72.3% and 55.3% respectively. Symptomatic dry eye (OSDI scores) was significantly associated with duration of diabetes (rs = 0.11, P = 0.028) and the presence of conjunctival disorders (OR = 2.09, P = 0.002). MGD was a risk factor for DED (OR = 1.99, P = 0.008); ocular surface damage, the presence of eye lid lesions, abnormal Schirmer test and reduced TBUT were significantly associated with MGD, the strongest predictor being ocular surface damage (OR = 3.21, P = 0.001). OSDI scores had no association with the presence of corneal lesions possibly due to reduced corneal sensitivity. CONCLUSION: DED and MGD were prevalent among the patients and therefore there is the need for dry eye assessment as a routine clinical management protocol for patients with type 2 diabetes. |
format | Online Article Text |
id | pubmed-9382471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Makerere Medical School |
record_format | MEDLINE/PubMed |
spelling | pubmed-93824712022-08-25 Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana Abu, Emmanuel K Ofori, Amanfo O Boadi-Kusi, Samuel B Ocansey, Stephen Yankah, Richard K Kyei, Samuel Awuku, Asante Y Afr Health Sci Articles OBJECTIVE: To evaluate dry eye disease and meibomian gland dysfunction among type 2 diabetes patients METHODS: A hospital-based cross-sectional study was conducted. Parameters assessed included meibum expressibility and quality, Schirmer test 1, tear breakup time (TBUT), ocular surface staining, blink rates and Ocular Surface Disease Index (OSDI) scores. Dry eye was diagnosed based on a combination of subjective symptoms, tear function and ocular surface staining. RESULTS: Prevalence of DED and MGD were 72.3% and 55.3% respectively. Symptomatic dry eye (OSDI scores) was significantly associated with duration of diabetes (rs = 0.11, P = 0.028) and the presence of conjunctival disorders (OR = 2.09, P = 0.002). MGD was a risk factor for DED (OR = 1.99, P = 0.008); ocular surface damage, the presence of eye lid lesions, abnormal Schirmer test and reduced TBUT were significantly associated with MGD, the strongest predictor being ocular surface damage (OR = 3.21, P = 0.001). OSDI scores had no association with the presence of corneal lesions possibly due to reduced corneal sensitivity. CONCLUSION: DED and MGD were prevalent among the patients and therefore there is the need for dry eye assessment as a routine clinical management protocol for patients with type 2 diabetes. Makerere Medical School 2022-03 /pmc/articles/PMC9382471/ /pubmed/36032480 http://dx.doi.org/10.4314/ahs.v22i1.36 Text en © 2022 Abu EK et al. https://creativecommons.org/licenses/by/4.0/Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Abu, Emmanuel K Ofori, Amanfo O Boadi-Kusi, Samuel B Ocansey, Stephen Yankah, Richard K Kyei, Samuel Awuku, Asante Y Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana |
title | Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana |
title_full | Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana |
title_fullStr | Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana |
title_full_unstemmed | Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana |
title_short | Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana |
title_sort | dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in ghana |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382471/ https://www.ncbi.nlm.nih.gov/pubmed/36032480 http://dx.doi.org/10.4314/ahs.v22i1.36 |
work_keys_str_mv | AT abuemmanuelk dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana AT oforiamanfoo dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana AT boadikusisamuelb dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana AT ocanseystephen dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana AT yankahrichardk dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana AT kyeisamuel dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana AT awukuasantey dryeyediseaseandmeibomianglanddysfunctionamongaclinicalsampleoftype2diabetespatientsinghana |